Rights and permissions
About this article
Cite this article
Orlistat weighs in against size of diabetes patients and costs. Pharmacoecon. Outcomes News 495, 5 (2006). https://doi.org/10.2165/00151234-200604950-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200604950-00012